Literature DB >> 32646867

Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.

Herb F Sewell1, Raymond M Agius2, Denise Kendrick3, Marcia Stewart4.   

Abstract

Entities:  

Year:  2020        PMID： 32646867     DOI： 10.1136/bmj.m2722

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies.

Authors:  Miao-Miao Zhao; Yun Zhu; Li Zhang; Gongxun Zhong; Linhua Tai; Shuo Liu; Guoliang Yin; Jing Lu; Qiong He; Ming-Jia Li; Ru-Xuan Zhao; Hao Wang; Weijin Huang; Changfa Fan; Lei Shuai; Zhiyuan Wen; Chong Wang; Xijun He; Qiuluan Chen; Banghui Liu; Xiaoli Xiong; Zhigao Bu; Youchun Wang; Fei Sun; Jin-Kui Yang
Journal:  Cell Discov       Date:  2022-06-06       Impact factor: 38.079

Review 2.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

3.  Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.

Authors:  Shihua Shi; Fei Wang; Huan Yao; Shuo Kou; Weihao Li; Bonan Chen; Yongcan Wu; Xiaomin Wang; Caixia Pei; Demei Huang; Yilan Wang; Pan Zhang; Yacong He; Zhenxing Wang
Journal:  Front Med (Lausanne)       Date:  2022-01-21

4.  Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods.

Authors:  Peter Natesan Pushparaj; Laila Abdullah Damiati; Iuliana Denetiu; Sherin Bakhashab; Muhammad Asif; Abrar Hussain; Sagheer Ahmed; Mohammad Hamid Hamdard; Mahmood Rasool
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

5.  The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.

Authors:  Stav Brown; Tal Brown; Paul S Cederna; Rod J Rohrich
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-09-28

6.  Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design.

Authors:  Christopher J Destache; Sarah J Aurit; David Schmidt; Laura Peet Erkes; Maureen Tierney; Renuga Vivekanandan
Journal:  Pharmacotherapy       Date:  2021-08-12       Impact factor: 6.251
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.